Published Jun 18, 2024

Labshares Announces Key Leadership Additions: Devon Lagasse Joins as VP of Growth and Emma Orfanos Is Promoted to Manager of Business Development

Press Releases

Newton, MA – June 2024

Labshares, a premier shared laboratory for emerging biotech and life science companies, is excited to announce two significant additions to its leadership team. Devon Lagasse has been appointed as Labshares’ new Vice President of Growth, and Emma Orfanos has been promoted to Manager of Business Development.

Devon Lagasse Joins Labshares as VP of Growth

Devon Lagasse brings a wealth of relevant experience to the position. With over 13 years at Eppendorf and MSD, Devon has a proven track record of developing deep relationships within the biotech and life science industry, expanding market presence, and driving growth. Her expertise will be invaluable as Labshares continues to expand its service offerings and footprint.

 

"We are thrilled to welcome Devon to our team," said Philip Borden, CEO of Labshares. "Her extensive industry knowledge and vision will be critical as we scale our operations and enhance our offerings to emerging biotech and life science companies. Devon will undoubtedly help us grow and reinforce Labshares’ position as the leading provider of shared lab services in Greater Boston."

Emma Orfanos Promoted to Manager of Business Development

Labshares is also proud to announce the promotion of Emma Orfanos to the role of Manager of Business Development. Emma has been with Labshares for two and a half years, during which she has demonstrated exceptional leadership and an ability to build and maintain relationships with Labshares members. She understands the needs of life science startups and her dedication to their success makes her a critical asset to the team.

"Emma has been instrumental in Labshares’ strong historic growth and she’ll continue to play a pivotal role in expanding our network and ensuring the success of our member companies. Her promotion is a testament to her hard work and outstanding contributions to Labshares."  said Phillip Borden, CEO of Labshares.

Related or similar articles

July 21, 2026

What We're Seeing Across the Biotech Industry

The biotech industry is showing encouraging signs of recovery. Hear Labshares CEO Philip Borden's perspective on the growing optimism across the market and what we're seeing firsthand throughout the biotech community.
Blog Posts
January 23, 2025

Labshares Enters 2025 with Significant Momentum

Labshares enters 2025 with strong momentum after expanding its biotech membership, surpassing 80% occupancy, adding $2 million in advanced lab equipment, and strengthening services and strategic partnerships.
Press Releases
June 18, 2024

Labshares Announces Key Leadership Additions: Devon Lagasse Joins as VP of Growth and Emma Orfanos Is Promoted to Manager of Business Development

Labshares appoints a Devon Lagasse as VP of Growth and promotes Emma Orfanos to Manager of Business Development, strengthening its leadership as the Greater Boston shared lab provider expands.
Press Releases